Contlicts of Interest, Authorship, and Disclosures in Industry-Related Scientific Publications: The Tort Bar and Editorial Oversight of Medical Journals

被引：45

作者：

Hirsch, Laurence J.

机构：

来源：

MAYO CLINIC PROCEEDINGS | 2009年 / 84卷 / 09期

关键词：

CONFLICTS-OF-INTEREST; MARKET-DRIVEN RESEARCH; RANDOMIZED-TRIALS; GASTROINTESTINAL TOXICITY; PHARMACEUTICAL-INDUSTRY; MYOCARDIAL-INFARCTION; RHEUMATOID-ARTHRITIS; CLINICAL-TRIALS; THE-LANCET; ROSIGLITAZONE;

D O I：

10.4065/84.9.811

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：811 / 821

页数：11

共 137 条

[1]

*AAMC TASK FORC, 2008, IND FUND MED ED REP, P22

[2]

Abbafati C, 2020, Lancet, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9

[3] The pharmaceutical industry - to whom is it accountable? [J].

Angell, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1902-1904

[4] Shattuck lecture - Evaluating the health risks of breast implants: The interplay of medical science, the law, and public opinion [J].

Angell, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (23) :1513-1518

[5]

[Anonymous], 2004, CAN MED ASSOC J, V170, P437

[6] Publishing commentary by authors with potential conflicts of interest: When, why, and how [J].

不详 .

ANNALS OF INTERNAL MEDICINE, 2004, 141 (01) :73-74

[7]

[Anonymous], 2004, LANCET, V363, P1335

[8]

[Anonymous], NY TIMES 0518

[9]

[Anonymous], NEUROLOGY

[10]

[Anonymous], 2008, UN REQ MAN SUBM BIOM

← 1 2 3 4 5 6 7 8 9 10 →